Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Aesica Partnering with Durham and Leeds Universities

Published: Friday, December 21, 2012
Last Updated: Friday, December 21, 2012
Bookmark and Share
CMO looking to identify alternative technologies to commercialize in 2013 following award of METRC Innovation Grant to develop improved or new API manufacturing processes.

Aesica has announced its second major innovation board partnership following the recent annual Genesis conference, a famed hotbed of future innovation.

The METRC Innovation Awards support new research between universities and companies in the fields of nanotechnology, science and engineering.

Aesica, the University of Durham and the University of Leeds were jointly awarded the grant to investigate and accelerate the development of processes that will improve cost efficiencies and increase manufacturing capacity at its Cramlington site.

Earlier this year, the company established the Aesica Innovation Board (AIB) to identify and commercialize new innovative technologies that help to bridge the growing R&D gap and the company is actively targeting academia and innovative businesses to form development partnerships with.

This latest partnership builds on the successful collaboration with Bradford University earlier in the year.

The new partnership with the University of Durham and the University of Leeds will be tasked with developing new or improved routes for the manufacture of an API.

A detailed kinetic study is already underway and based on this, new flow processes will be developed before being scaled up at the Aesica Cramlington plant.

"Professor Andrew Whiting from Durham University and Professor Frans Muller from Leeds University will work together on a new collaborative METRC-funded project with the global pharmaceutical manufacturer, Aesica Pharmaceuticals. Alternative manufacturing processes will be investigated to increase the manufacturing capacity of the API, as well as exploring how to achieve cost efficiencies at the Aesica Cramlington manufacturing site, which is based in the North East of England. If, as expected, this joint collaboration leads to commercialization of new processes, it would become a key partnership." Prof. Steve Armes, Academic Director of METRC.

“We are delighted to officially embark on this partnership with Andy at the University of Durham and Frans at the University of Leeds. Andy and Frans have been hugely supportive of the mandate of the Aesica Innovation Board: to bring together the best that industry and academia have to offer, in the interests of pharmaceutical innovation. The successful METRC application will allow us to invest in researching an improved manufacturing process, and critically, establish a successful model for future collaboration with Durham and Leeds universities” Barrie Rhodes, Director of Technology Development, Aesica Pharmaceuticals.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bespak and Aesica Unveil New Single Source Supply Chain Solution
Supply chain solution for drug delivery device and pharmaceutical manufacturing services.
Friday, November 13, 2015
Aesica Introduces New Service Model with One CDMO
The company’s solution radically simplifies supply chain management – optimizing efficiency, improving performance and bringing products to market faster.
Wednesday, October 21, 2015
Aesica Launches New Brand Identity
Official launch to the market is planned for 13th October.
Tuesday, October 13, 2015
Aesica Secures Continuing FDA Approval of its Bulk Manufacture and Packaging Sites
FDA inspection results means Aesica will continue to grow its manufacturing and packaging services for pharmaceutical products for the US market.
Tuesday, February 03, 2015
Aesica Appoints VP, Business Development and Business Development Director
Appointment of Detlef Behrens and Sven Wrabletz for finished dose to drive service in Europe and achieve further growth.
Friday, October 31, 2014
Aesica Appoints New Product Release Manager
Company announces appointment of Adam Burgess.
Wednesday, August 20, 2014
Aesica Zwickau Marks 20th Anniversary
Continued growth and expansion of Company’s encapsulation services business.
Saturday, July 19, 2014
Aesica Recruits New Business Development Manager
Appointment of Nadine K. Reuter to aid sales drive across German, Austrian and Swiss Markets.
Thursday, July 03, 2014
Aesica Collaborates with QAD to Meet CFDA’s Shortened Serialization Deadline
The new system was implemented within three months.
Saturday, June 28, 2014
Aesica Successfully Introduces Serialization Services at Italian Site
Initiates commercial production of two product lines for the Chinese market.
Thursday, April 17, 2014
Aesica Led Consortium Wins Technology Strategy Board Grant
Funding secured for the consortium’s project to investigate an industrial biotechnology process to enable improved manufacture of an API.
Tuesday, April 08, 2014
Aesica Completes the Validation of its High Capacity Manufacturing Facility
$45m (USD) has been invested at its Queenborough, UK site.
Saturday, March 15, 2014
Aesica Appoints Ian Muir to Commercial Managing Director Position
Key functions centre on the Group’s commercial business and product pipeline development across API, formulation development and formulated products.
Tuesday, February 04, 2014
Aesica Awarded NEPIC Industry Award
Corporate HR Manager wins NEPIC 2014 Young Achiever Accolade within the Pharmaceutical category.
Thursday, January 30, 2014
Aesica Appoints New Site Manufacturing Manager at Cramlington Facility
Tasked with optimizing performance schedules, including 4 new products for 2014.
Tuesday, November 26, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos